| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| B Group, Inc. | 13% | $8,820,000 | 3,000,000 | The B Group, Inc. | 18 Aug 2025 | |||
| Anson Funds Management LP | 9.3% | +33% | $5,151,970 | +$1,367,184 | 1,604,975 | +36% | Anson Funds Management LP | 30 Jun 2025 |
As of 31 Dec 2025, 28 institutional investors reported holding 5,235,517 shares of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP). This represents 22% of the company’s total 23,771,791 outstanding shares.
The largest institutional shareholders of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) together control 22% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Anson Funds Management LP | 13% | 3,043,957 | +50% | 1.2% | $8,249,123 |
| VANGUARD GROUP INC | 3.1% | 729,842 | +36% | 0% | $1,977,871 |
| COMMONWEALTH EQUITY SERVICES, LLC | 1.5% | 366,631 | 0% | $993,570 | |
| AdvisorShares Investments LLC | 1.4% | 328,004 | -4.1% | 0.15% | $888,891 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.92% | 218,866 | +18% | 0% | $593,212 |
| Bleakley Financial Group, LLC | 0.49% | 117,204 | 0.01% | $317,623 | |
| STATE STREET CORP | 0.37% | 86,984 | +14% | 0% | $235,727 |
| BlackRock, Inc. | 0.35% | 82,654 | +26% | 0% | $223,992 |
| Global Retirement Partners, LLC | 0.17% | 39,300 | 0% | $106,503 | |
| JANE STREET GROUP, LLC | 0.16% | 38,065 | -48% | 0% | $103,156 |
| One Wealth Management Investment & Advisory Services, LLC | 0.16% | 37,873 | +35% | 0.11% | $102,636 |
| Chicago Partners Investment Group LLC | 0.14% | 33,421 | -20% | 0% | $72,524 |
| NORTHERN TRUST CORP | 0.12% | 28,947 | +1.2% | 0% | $78,446 |
| TWO SIGMA INVESTMENTS, LP | 0.07% | 17,436 | -67% | 0% | $47,252 |
| Point72 Asset Management, L.P. | 0.07% | 15,979 | 0% | $43,303 | |
| SJBENEN ADVISORY, LLC | 0.06% | 15,000 | 0% | 0.06% | $40,650 |
| Ethos Financial Group, LLC | 0.05% | 11,900 | 0% | 0% | $32,249 |
| MORGAN STANLEY | 0.04% | 10,029 | -9.5% | 0% | $27,179 |
| UBS Group AG | 0.01% | 3,538 | -98% | 0% | $9,588 |
| BANK OF AMERICA CORP /DE/ | 0.01% | 3,239 | -4.7% | 0% | $8,777 |
| SBI Securities Co., Ltd. | 0.01% | 2,500 | 0% | 0% | $6,775 |
| ROYAL BANK OF CANADA | 0.01% | 2,000 | 0% | $5,000 | |
| WELLS FARGO & COMPANY/MN | 0.01% | 2,000 | 0% | 0% | $5,420 |
| OSAIC HOLDINGS, INC. | 0% | 90 | -92% | 0% | $243 |
| JPMORGAN CHASE & CO | 0% | 34 | 0% | 0% | $92 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 5,235,517 | $14,169,868 | +$3,242,026 | $2.71 | 28 |
| 2025 Q3 | 3,956,630 | $13,043,325 | +$3,167,783 | $3.30 | 24 |
| 2025 Q2 | 2,994,368 | $9,761,438 | +$2,410,566 | $3.26 | 25 |
| 2025 Q1 | 2,260,524 | $4,602,262 | +$2,464,504 | $2.05 | 22 |
| 2024 Q4 | 1,048,642 | $2,306,847 | +$754,487 | $2.20 | 25 |
| 2024 Q3 | 714,327 | $1,207,232 | +$328,214 | $1.69 | 18 |
| 2024 Q2 | 510,346 | $1,261,065 | +$1,261,065 | $2.44 | 18 |